Trgovina Hikma Pharmaceuticals PLC - HIK CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.08 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.023178% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.00126% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | GBP | ||||||||
Kritje | 20% | ||||||||
Borza | United Kingdom of Great Britain and Northern Ireland | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Hikma Pharmaceuticals PLC ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 18 |
Odpri* | 17.76 |
Enoletna sprememba* | 4.35% |
Dnevni razpon* | 17.76 - 17.99 |
Razpon 52 wk | 11.75-19.16 |
Povprečni obseg (10 dni) | 438.85K |
Povprečni obseg (3 meseci) | 8.19M |
Tržna kapitalizacija | 3.95B |
Razmerje P/E | 26.87 |
Število delnic v obtoku | 220.99M |
Prihodki | 2.03B |
EPS | 0.67 |
Dividenda (donosnost v %) | 2.565 |
Beta | 0.35 |
Datum naslednjega zaslužka | Aug 3, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
May 30, 2023 | 18.00 | -0.45 | -2.44% | 18.45 | 18.58 | 17.88 |
May 26, 2023 | 18.51 | 0.29 | 1.59% | 18.22 | 18.53 | 18.06 |
May 25, 2023 | 18.37 | 0.00 | 0.00% | 18.37 | 18.55 | 18.09 |
May 24, 2023 | 18.27 | 0.03 | 0.16% | 18.24 | 18.42 | 17.99 |
May 23, 2023 | 18.43 | 0.16 | 0.88% | 18.27 | 18.50 | 18.19 |
May 22, 2023 | 18.41 | 0.28 | 1.54% | 18.13 | 18.42 | 18.13 |
May 19, 2023 | 18.22 | -0.08 | -0.44% | 18.30 | 18.44 | 18.10 |
May 18, 2023 | 18.28 | 0.07 | 0.38% | 18.21 | 18.46 | 18.20 |
May 17, 2023 | 18.31 | -0.01 | -0.05% | 18.32 | 18.34 | 17.88 |
May 16, 2023 | 18.32 | -0.16 | -0.87% | 18.48 | 18.54 | 18.17 |
May 15, 2023 | 18.48 | 0.04 | 0.22% | 18.44 | 18.59 | 18.34 |
May 12, 2023 | 18.55 | 0.01 | 0.05% | 18.54 | 18.62 | 18.50 |
May 11, 2023 | 18.56 | 0.22 | 1.20% | 18.34 | 18.68 | 18.34 |
May 10, 2023 | 18.57 | 0.03 | 0.16% | 18.54 | 18.84 | 18.46 |
May 9, 2023 | 18.54 | -0.24 | -1.28% | 18.78 | 19.13 | 18.47 |
May 5, 2023 | 18.75 | 0.12 | 0.64% | 18.63 | 18.77 | 18.33 |
May 4, 2023 | 18.75 | 0.54 | 2.97% | 18.21 | 18.78 | 18.16 |
May 3, 2023 | 18.40 | 0.05 | 0.27% | 18.35 | 18.71 | 18.25 |
May 2, 2023 | 18.25 | -0.15 | -0.82% | 18.40 | 18.49 | 18.23 |
Apr 28, 2023 | 18.45 | 0.37 | 2.05% | 18.08 | 18.83 | 17.67 |
Hikma Pharmaceuticals PLC Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Thursday, November 2, 2023 | ||
Čas (UTC) (UTC) 07:00 | Država GB
| Dogodek November 2023 Hikma Pharmaceuticals PLC Trading Statement Release November 2023 Hikma Pharmaceuticals PLC Trading Statement ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 2517 | 2553 | 2341 | 2203 | 2076 |
Prihodki | 2517 | 2553 | 2341 | 2203 | 2076 |
Celotni stroški prihodkov | 1252 | 1252 | 1128 | 1108 | 1004 |
Bruto dobiček | 1265 | 1301 | 1213 | 1095 | 1072 |
Celotni odhodki iz poslovanja | 2208 | 1955 | 1739 | 1669 | 1731 |
Celotna prodaja/splošni/upravni stroški Odhodki | 509 | 488 | 464 | 453 | 437 |
Raziskave in razvoj | 144 | 143 | 137 | 126 | 118 |
Nenavadni odhodki (prihodki) | 200 | -39 | -76 | -60 | 104 |
Other Operating Expenses, Total | 11 | 38 | 44 | 8 | 68 |
Prihodki iz poslovanja | 309 | 598 | 602 | 534 | 345 |
Prihodki (odhodki) od obresti, neto Neoperativni | -65 | -41 | -33 | -27 | -39 |
Drugo, neto | -11 | -13 | -11 | -16 | -13 |
Čisti dobiček pred obdavčitvijo | 233 | 544 | 558 | 491 | 293 |
Čisti dobiček po davkih | 191 | 420 | 430 | 487 | 285 |
Manjšinski delež | -3 | 1 | 1 | -1 | -3 |
Čisti dobiček pred dodatnimi postavkami | 188 | 421 | 431 | 486 | 282 |
Čisti dobiček | 188 | 421 | 431 | 486 | 282 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 188 | 421 | 431 | 486 | 282 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 188 | 421 | 431 | 486 | 282 |
Prilagoditev za redčenje | 0 | ||||
Popravljen čisti dobiček | 188 | 421 | 431 | 486 | 282 |
Popravljene ponderirane povprečne delnice | 225 | 233 | 238 | 243 | 242 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.83556 | 1.80687 | 1.81092 | 2 | 1.16529 |
Dividends per Share - Common Stock Primary Issue | 0.55789 | 0.55055 | 0.50649 | 0.4714 | 0.37647 |
Popravljen normalizirani dobiček na enoto čistega dobička | 2.03111 | 1.66094 | 1.4958 | 2.16049 | 1.90496 |
Skupaj izredne postavke | 0 | ||||
Depreciation / Amortization | 92 | 73 | 42 | 34 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Skupni prihodki | 1304 | 1213 | 1337 | 1216 | 1209 |
Prihodki | 1304 | 1213 | 1337 | 1216 | 1209 |
Celotni stroški prihodkov | 662 | 590 | 652 | 600 | 598 |
Bruto dobiček | 642 | 623 | 685 | 616 | 611 |
Celotni odhodki iz poslovanja | 1244 | 964 | 1082 | 873 | 900 |
Celotna prodaja/splošni/upravni stroški Odhodki | 253 | 256 | 256 | 232 | 235 |
Raziskave in razvoj | 75 | 69 | 84 | 59 | 75 |
Depreciation / Amortization | 49 | 43 | 44 | 29 | 21 |
Nenavadni odhodki (prihodki) | 193 | 7 | 24 | -63 | -44 |
Other Operating Expenses, Total | 12 | -1 | 22 | 16 | 15 |
Prihodki iz poslovanja | 60 | 249 | 255 | 343 | 309 |
Prihodki (odhodki) od obresti, neto Neoperativni | -42 | -34 | -30 | -24 | -25 |
Čisti dobiček pred obdavčitvijo | 18 | 215 | 225 | 319 | 284 |
Čisti dobiček po davkih | 17 | 174 | 172 | 248 | 218 |
Manjšinski delež | -2 | -1 | 1 | 0 | 1 |
Čisti dobiček pred dodatnimi postavkami | 15 | 173 | 173 | 248 | 219 |
Čisti dobiček | 15 | 173 | 173 | 248 | 219 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 15 | 173 | 173 | 248 | 219 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 15 | 173 | 173 | 248 | 219 |
Popravljen čisti dobiček | 15 | 173 | 173 | 248 | 219 |
Popravljene ponderirane povprečne delnice | 222 | 228 | 234 | 232 | 232.881 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.06757 | 0.75877 | 0.73932 | 1.06897 | 0.9404 |
Dividends per Share - Common Stock Primary Issue | 0.35715 | 0.19 | 0.37405 | 0.18 | 0.33778 |
Popravljen normalizirani dobiček na enoto čistega dobička | 1.1982 | 0.83772 | 0.90171 | 0.75862 | 0.76005 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 1999 | 2094 | 1922 | 1848 | 1668 |
Denarna sredstva in kratkoročne naložbe | 292 | 450 | 347 | 465 | 276 |
Cash | 159 | 155 | 85 | 94 | 112 |
Denarna sredstva in ustrezniki | 1 | 22 | 35 | 39 | 36 |
Kratkoročne naložbe | 132 | 273 | 227 | 332 | 128 |
Celotne terjatve, neto | 841 | 876 | 734 | 749 | 748 |
Accounts Receivable - Trade, Net | 777 | 781 | 662 | 637 | 654 |
Total Inventory | 776 | 695 | 757 | 568 | 528 |
Prepaid Expenses | 74 | 65 | 58 | 49 | 57 |
Other Current Assets, Total | 16 | 8 | 26 | 17 | 59 |
Total Assets | 4471 | 4372 | 4135 | 3930 | 3497 |
Property/Plant/Equipment, Total - Net | 1081 | 1146 | 1068 | 962 | 870 |
Property/Plant/Equipment, Total - Gross | 2008 | 1955 | 1841 | 1690 | 1549 |
Accumulated Depreciation, Total | -927 | -809 | -773 | -728 | -679 |
Goodwill, Net | 389 | 285 | 289 | 282 | 279 |
Intangibles, Net | 735 | 607 | 587 | 552 | 487 |
Long Term Investments | 52 | 46 | 34 | 29 | 38 |
Other Long Term Assets, Total | 215 | 194 | 235 | 257 | 155 |
Total Current Liabilities | 1077 | 1016 | 1028 | 1471 | 893 |
Accounts Payable | 291 | 262 | 279 | 286 | 263 |
Accrued Expenses | 171 | 194 | 175 | 173 | 185 |
Notes Payable/Short Term Debt | 75 | 64 | 117 | 60 | 65 |
Current Port. of LT Debt/Capital Leases | 73 | 57 | 51 | 518 | 10 |
Other Current Liabilities, Total | 467 | 439 | 406 | 434 | 370 |
Total Liabilities | 2336 | 1919 | 2000 | 1813 | 1812 |
Total Long Term Debt | 1135 | 725 | 764 | 107 | 562 |
Long Term Debt | 1074 | 651 | 692 | 48 | 539 |
Capital Lease Obligations | 61 | 74 | 72 | 59 | 23 |
Deferred Income Tax | 19 | 24 | 31 | 20 | 16 |
Minority Interest | 13 | 14 | 13 | 12 | 12 |
Other Liabilities, Total | 92 | 140 | 164 | 203 | 329 |
Total Equity | 2135 | 2453 | 2135 | 2117 | 1685 |
Common Stock | 40 | 42 | 41 | 41 | 40 |
Additional Paid-In Capital | 282 | 282 | 282 | 282 | 282 |
Retained Earnings (Accumulated Deficit) | 2129 | 2353 | 2011 | 2030 | 1618 |
Treasury Stock - Common | 0 | -1 | -1 | ||
Other Equity, Total | -316 | -224 | -199 | -235 | -254 |
Total Liabilities & Shareholders’ Equity | 4471 | 4372 | 4135 | 3930 | 3497 |
Total Common Shares Outstanding | 220.236 | 231.498 | 230.458 | 242.319 | 241.455 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 1999 | 2144 | 2094 | 1955 | 1922 |
Denarna sredstva in kratkoročne naložbe | 292 | 393 | 450 | 346 | 347 |
Denarna sredstva in ustrezniki | 1 | 23 | 22 | 2 | 323 |
Kratkoročne naložbe | 132 | 94 | 273 | 101 | 24 |
Celotne terjatve, neto | 841 | 893 | 811 | 780 | 734 |
Accounts Receivable - Trade, Net | 777 | 784 | 719 | 693 | 662 |
Total Inventory | 776 | 765 | 695 | 736 | 757 |
Prepaid Expenses | 74 | 80 | 65 | 78 | 58 |
Other Current Assets, Total | 16 | 13 | 73 | 15 | 26 |
Total Assets | 4471 | 4747 | 4372 | 4180 | 4135 |
Property/Plant/Equipment, Total - Net | 1081 | 1132 | 1146 | 1061 | 1068 |
Goodwill, Net | 389 | 394 | 285 | 286 | 289 |
Intangibles, Net | 735 | 857 | 607 | 620 | 587 |
Long Term Investments | 52 | 52 | 46 | 36 | 34 |
Other Long Term Assets, Total | 215 | 168 | 194 | 222 | 235 |
Total Current Liabilities | 1077 | 1010 | 1016 | 960 | 1028 |
Accounts Payable | 291 | 255 | 262 | 226 | 279 |
Accrued Expenses | 171 | 160 | 194 | 145 | 175 |
Notes Payable/Short Term Debt | 75 | 76 | 64 | 132 | 117 |
Current Port. of LT Debt/Capital Leases | 73 | 61 | 57 | 49 | 51 |
Other Current Liabilities, Total | 467 | 458 | 439 | 408 | 406 |
Total Liabilities | 2336 | 2571 | 1919 | 1890 | 2000 |
Total Long Term Debt | 1135 | 1414 | 725 | 751 | 764 |
Long Term Debt | 1074 | 1340 | 651 | 676 | 692 |
Capital Lease Obligations | 61 | 74 | 74 | 75 | 72 |
Deferred Income Tax | 19 | 24 | 24 | 21 | 31 |
Minority Interest | 13 | 15 | 14 | 13 | 13 |
Other Liabilities, Total | 92 | 108 | 140 | 145 | 164 |
Total Equity | 2135 | 2176 | 2453 | 2290 | 2135 |
Common Stock | 40 | 41 | 42 | 41 | 41 |
Additional Paid-In Capital | 282 | 282 | 282 | 282 | 282 |
Retained Earnings (Accumulated Deficit) | 2129 | 2143 | 2353 | 2197 | 2011 |
Treasury Stock - Common | 0 | 0 | |||
Other Equity, Total | -316 | -290 | -224 | -230 | -199 |
Total Liabilities & Shareholders’ Equity | 4471 | 4747 | 4372 | 4180 | 4135 |
Total Common Shares Outstanding | 220.236 | 220.113 | 231.498 | 231.432 | 230.458 |
Cash | 159 | 276 | 155 | 243 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | 233 | 544 | 558 | 491 | 293 |
Denarna sredstva iz poslovanja | 530 | 638 | 464 | 472 | 430 |
Denarna sredstva iz poslovanja | 372 | 145 | 91 | 73 | 69 |
Amortization | 26 | 40 | |||
Nedenarne postavke | 112 | 108 | 84 | 34 | 116 |
Cash Taxes Paid | 55 | 129 | 61 | 108 | 63 |
Denarna sredstva Plačane obresti | 68 | 50 | 39 | 44 | 51 |
Spremembe v obratnem kapitalu | -187 | -159 | -269 | -152 | -88 |
Denarna sredstva pri naložbenju | -607 | -238 | -283 | -151 | -96 |
Kapitalski izdatki | -225 | -229 | -224 | -186 | -139 |
Celotne druge postavke denarnih tokov pri naložbenju | -382 | -9 | -59 | 35 | 43 |
Denarna sredstva pri financiranju | -58 | -287 | -298 | -155 | -278 |
Postavke denarnega toka pri financiranju | -77 | -53 | -34 | -48 | -53 |
Total Cash Dividends Paid | -125 | -120 | -109 | -97 | -84 |
Izdaja (odplačilo) delnic, neto | -303 | 0 | -375 | ||
Izdaja (odplačilo) dolga, neto | 447 | -114 | 220 | -10 | -141 |
Učinki deviznih tečajev | -21 | -10 | -2 | 0 | -7 |
Neto sprememba denarnih sredstev | -156 | 103 | -119 | 166 | 49 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 233 | 215 | 544 | 319 | 558 |
Cash From Operating Activities | 530 | 169 | 638 | 224 | 464 |
Cash From Operating Activities | 372 | 95 | 145 | 44 | 91 |
Amortization | |||||
Non-Cash Items | 110 | 48 | 108 | 28 | 84 |
Cash Taxes Paid | 55 | 44 | 129 | 88 | 61 |
Cash Interest Paid | 68 | 27 | 50 | 25 | 39 |
Changes in Working Capital | -185 | -189 | -159 | -167 | -269 |
Cash From Investing Activities | -607 | -506 | -238 | -104 | -283 |
Capital Expenditures | -225 | -119 | -229 | -94 | -224 |
Other Investing Cash Flow Items, Total | -382 | -387 | -9 | -10 | -59 |
Cash From Financing Activities | -58 | 291 | -287 | -112 | -298 |
Financing Cash Flow Items | -77 | -33 | -53 | -26 | -34 |
Total Cash Dividends Paid | -125 | -83 | -120 | -78 | -109 |
Issuance (Retirement) of Debt, Net | 447 | 710 | -114 | -8 | 220 |
Foreign Exchange Effects | -21 | -9 | -10 | -9 | -2 |
Net Change in Cash | -156 | -55 | 103 | -1 | -119 |
Issuance (Retirement) of Stock, Net | -303 | -303 | 0 | 0 | -375 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Darhold Ltd | Corporation | 27.1507 | 60000000 | 0 | 2023-02-22 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 5.2296 | 11556882 | 0 | 2023-02-22 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.1955 | 11481557 | -486547 | 2023-05-22 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.9869 | 4390912 | 1080315 | 2022-12-12 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 1.8463 | 4080196 | 50657 | 2023-05-01 | LOW |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 1.784 | 3942466 | 95668 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.7473 | 3861317 | 5678 | 2023-05-01 | LOW |
Mawer Investment Management Ltd. | Investment Advisor | 1.2789 | 2826219 | 1441154 | 2023-01-31 | LOW |
Epoch Investment Partners, Inc. | Investment Advisor | 0.9915 | 2191152 | 716350 | 2022-12-01 | LOW |
California State Teachers Retirement System | Pension Fund | 0.9822 | 2170477 | 197506 | 2022-06-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 0.9057 | 2001573 | 62506 | 2022-12-12 | LOW |
Polar Capital LLP | Investment Advisor/Hedge Fund | 0.8883 | 1963002 | 1692712 | 2023-03-31 | LOW |
Templeton Investment Counsel, L.L.C. | Investment Advisor/Hedge Fund | 0.8371 | 1850000 | 1850000 | 2022-06-06 | LOW |
Aegon Asset Management Ltd | Investment Advisor | 0.8285 | 1830945 | 0 | 2023-05-01 | LOW |
Darwazeh (Mazen Samih Taleb) | Individual Investor | 0.6116 | 1351507 | 43150 | 2023-04-17 | LOW |
M & G Investment Management Ltd. | Investment Advisor | 0.5862 | 1295387 | 165634 | 2023-05-01 | LOW |
Newton Investment Management Ltd. | Investment Advisor | 0.5714 | 1262704 | -441 | 2023-04-30 | LOW |
Al-Husry (Ali) | Individual Investor | 0.5262 | 1162811 | 0 | 2023-02-22 | LOW |
GAM International Management Ltd. | Investment Advisor/Hedge Fund | 0.5023 | 1110079 | 217500 | 2022-12-12 | MED |
Premier Asset Management Ltd | Investment Advisor/Hedge Fund | 0.4626 | 1022221 | -37363 | 2023-01-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Hikma Company profile
O družbi Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals Plc je farmacevtsko podjetje. Družba se osredotoča na razvoj, proizvodnjo, trženje in prodajo širokega nabora generičnih farmacevtskih izdelkov, izdelkov pod blagovno znamko in farmacevtskih izdelkov z licenco v trdnih, poltrdnih, tekočih in injiciranih končnih farmacevtskih oblikah. Družba posluje v treh segmentih, kot so injekcijska zdravila, generična zdravila in blagovne znamke. Področje injiciranja razvija in proizvaja generične izdelke za injiciranje, ki se uporabljajo predvsem v bolnišnicah. Področje generičnih zdravil razvija in proizvaja generična zdravila za peroralno uporabo in druga generična zdravila, ki se ne injicirajo. Področje Branded razvija in proizvaja generična zdravila z blagovno znamko ter trži in prodaja patentirane izdelke z licenco na Bližnjem vzhodu/Severni Afriki (MENA). Izdelki družbe se prodajajo na maloprodajnih in bolnišničnih trgih. Svoje izdelke trži tudi v Kanadi, in sicer približno 25 izdelkov za sterilne injekcije, tri oftalmološke izdelke, za katere je pridobila licenco, in sedem dodatnih izdelkov v pripravi.
Industry: | Pharmaceuticals (NEC) |
1 New Burlington Place
LONDON
W1S 2HR
GB
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com